Global & Public Health (all articles)
Systematic Review: Filtering Facepiece Respirator (N95 Respirator) Reprocessing
4 Mar, 2021 | 08:58h | UTCFiltering Facepiece Respirator (N95 Respirator) Reprocessing: A Systematic Review – JAMA
Commentary on Twitter
Reuse of N95 and related masks, a review of 42 studies https://t.co/PqnC5kzlrW
Comparison of merits of 5 different methods for retaining filtration https://t.co/PqnC5kzlrW@JAMA_current by @MSchumm90 and colleagues @UCLAHealth 😷 pic.twitter.com/Q6UMhhUhLy— Eric Topol (@EricTopol) March 3, 2021
Opinion | COVID vaccination studies: plan now to pool data, or be bogged down in confusion
4 Mar, 2021 | 08:48h | UTCCOVID vaccination studies: plan now to pool data, or be bogged down in confusion – Nature
We still don’t know how well Covid vaccines stop transmission
4 Mar, 2021 | 08:46h | UTCWe Still Don’t Know How Well Covid Vaccines Stop Transmission – Wired
Commentary on Twitter
Do vaccines stop the coronavirus from spreading? Almost certainly! Do they block 89.4% of transmission? Probably not.
Here's what the new data out of Israel and the UK does (and doesn't) tell us about how to safely navigate a semi-vaccinated society:https://t.co/JZADHp3PrH
— Megan Molteni (@MeganMolteni) February 25, 2021
The myth of ‘good’ and ‘bad’ Covid vaccines: Why false perceptions overlook facts, and could breed resentment
4 Mar, 2021 | 08:44h | UTC
COVID-19 and healthcare workers: a rapid systematic review into risks and preventive measures
4 Mar, 2021 | 08:42h | UTC
Study: Smoking is associated with a higher risk of hospitalization and mortality from COVID-19 in a dose-dependent manner
4 Mar, 2021 | 08:41h | UTCCommentary: Heavy smokers have DOUBLE the risk of dying of COVID-19 – Daily Mail
Addressing Antibiotic Overuse in the Outpatient Setting: Lessons From Behavioral Economics
4 Mar, 2021 | 08:27h | UTC
The hidden burden of eating disorders: an extension of estimates from the Global Burden of Disease Study 2019
4 Mar, 2021 | 08:29h | UTCInvited Commentary: Some of the burden of eating disorders is still hidden – The Lancet Psychiatry
New WHO report: population-based screening for cardiovascular disease risk factors does not reduce CVD mortality
4 Mar, 2021 | 08:20h | UTC
The vaccine race against the coronavirus variants, explained
3 Mar, 2021 | 08:52h | UTCThe vaccine race against the coronavirus variants, explained – Vox
WHO Guideline recommends against Hydroxychloroquine to prevent Covid-19
3 Mar, 2021 | 08:56h | UTCA living WHO guideline on drugs to prevent covid-19 – The BMJ
See also: WHO Living guideline: Drugs to prevent COVID-19 – World Health Organization
Commentaries: WHO advises against hydroxychloroquine to curb COVID-19 – CIDRAP AND WHO panel issues strong advice against hydroxychloroquine for COVID-19 – Reuters
Commentary on Twitter
The anti-inflammatory drug hydroxychloroquine should NOT be used to prevent infection in people who do not have #COVID19, according to the latest WHO clinical care guidance https://t.co/Oi2NJQMwiZ pic.twitter.com/0UQr78hNk4
— World Health Organization (WHO) (@WHO) March 2, 2021
More transmissible and evasive SARS-CoV-2 variant growing rapidly in Brazil
3 Mar, 2021 | 08:53h | UTCOriginal study (preprint): Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil
Commentaries: Covid Brazil variant ‘may spread more easily’ – BBC AND Brazil coronavirus variant: what is it and why is it a concern? An expert explains – The Conversation
Covid-19: Single dose of Pfizer and Oxford vaccines cuts risk of hospital admission by 80% in over 80s, data suggest
3 Mar, 2021 | 08:51h | UTC
Commentary on Twitter
Both the Pfizer BioNTech and the Oxford AstraZeneca vaccines are highly effective in reducing covid-19 infections and protecting against severe disease in older adults, preliminary data show https://t.co/THSv5kiIVt
— The BMJ (@bmj_latest) March 2, 2021
How to make ‘immunity passports’ more ethical
3 Mar, 2021 | 08:46h | UTCHow to Make ‘Immunity Passports’ More Ethical – Scientific American
Related: Twelve criteria for the development and use of COVID-19 vaccine passports
USPSTF Draft Statement: Screening for Chlamydia and Gonorrhea in Sexually Active Women
3 Mar, 2021 | 08:43h | UTCScreening for Chlamydia and Gonorrhea – U.S. Preventive Services Task Force
6 Steps to Better Imaging for Transgender Patients
3 Mar, 2021 | 08:39h | UTCSummary: 6 Steps to Better Imaging for Transgender Patients – Diagnostic Imaging
Original article: Imaging Health and Radiology Care of Transgender Patients: A Call to Build Evidence-Based Best Practices – Journal of the American College of Cardiology ($)
Commentary on Twitter
71% of transgender patients report having a negative imaging encounter. Researchers led by @UVMHealth offer 6 tips in @JACRJournal for improving imaging for this patient group. https://t.co/Ixha7tXF3v
— Diagnostic Imaging (@Dx_imaging) March 2, 2021
ACOG Committee Opinion: Health care for transgender and gender diverse individuals
3 Mar, 2021 | 08:41h | UTCHealth Care for Transgender and Gender Diverse Individuals – Obstetrics & Gynecology
Requests for brand name over generic prescription drugs cost the Medicare program $1.7 billion in a single year, study finds
3 Mar, 2021 | 08:31h | UTCOriginal study: Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program – JAMA Network Open
Commentary on Twitter
Economic evaluation finds prescribers & patients motivated 30% of branded drug dispensing in Medicare Part D, an incremental annual cost of $1.7 billion Medicare & $270 million to patients vs switching to generics. @dr_msocal @GeBaiDC @JohnsHopkinsSPH https://t.co/MkVJdzLczG
— JAMA Network Open (@JAMANetworkOpen) March 3, 2021
M-A: Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults
3 Mar, 2021 | 08:30h | UTC
Another study shows higher antibody titer responses to a single dose of mRNA vaccine among patients with previous COVID-19 infection
2 Mar, 2021 | 02:13h | UTCRelated: Studies: Single dose of vaccine acts as ‘booster’ in those with prior COVID-19 infection (studies and commentary)
WHO: Roadmap to improve and ensure good indoor ventilation in the context of COVID-19
2 Mar, 2021 | 02:15h | UTC
Commentary on Twitter
Wonderful guidance from @WHO on ventilation. Here are a couple of pages for non-residential settings. All the things we've been talking about: minimum 10 L/s/person, open doors & windows for cross-ventilation, use exhaust fans, filtration. https://t.co/umMzhiqKza pic.twitter.com/UEZLahi87v
— Linsey Marr https://www.threads.net/@linseycmarr (@linseymarr) March 1, 2021
Scaling up COVID-19 rapid antigen tests: promises and challenges
2 Mar, 2021 | 02:09h | UTCScaling up COVID-19 rapid antigen tests: promises and challenges – The Lancet Infectious Diseases
Vaccinating the oldest against COVID-19 saves both the most lives and most years of life
2 Mar, 2021 | 02:04h | UTCCommentary: Vaccinating Oldest First for COVID Saves the Most Lives: Study – HealthDay
Commentary on Twitter
The policy of vaccinating the oldest vs covid-19:
Most lives saved and most years of life saved, the latter representing an unexpected extent of life expectancy gainhttps://t.co/KgLrl1j2xt @PNASNews by @jrgoldstein1 and colleagues pic.twitter.com/4MWZRa1i11— Eric Topol (@EricTopol) February 25, 2021
Who gets a COVID-19 vaccine and who pays? The need for economic analysis
2 Mar, 2021 | 02:02h | UTC
Commentary on Twitter
NEW from @CGDev and @idsihealth — experts look at the potential of Health Technology Assessment (HTA) on informing how much #COVID19 vaccine countries should buy, who should pay, and how vaccines can be most effectively delivered.
Read: https://t.co/KuMZSARSEF #GlobalHealth
— Center for Global Development (@CGDev) February 24, 2021
CDC Report: Reduction in severe COVID-19 following the implementation of a national vaccination program in Israel
28 Feb, 2021 | 21:54h | UTCCommentary: Israeli data suggest mass vaccinations led to drop in severe Covid cases, CDC study finds – CNBC
Commentary on Twitter
A new @CDCMMWR from Israel shows preliminary evidence of the effectiveness of vaccination in preventing severe cases of #COVID19. Vaccination among people who are eligible to receive a COVID-19 vaccine can potentially reduce severe disease from COVID-19. https://t.co/CaUAXRVaS4 pic.twitter.com/GyaulMONpZ
— CDC (@CDCgov) February 26, 2021